Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Morgello

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Medical Virology|March 21, 2024
Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllersMattia Trunfio, Bin Tang, Oluwakemi Okwuegbuna, et al.
Journal of Neurovirology|June 13, 2015
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV diseaseAlbert M Anderson, Christine Fennema-Notestine, Anya Umlauf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient CohortAlison C Kearns, Fengming Liu, Shen Dai, et al.
The Lancet. HIV|June 19, 2019
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort studyAlessandro Livelli, Florin Vaida, Ronald J Ellis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluidDavid Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Clinical and Experimental Neuropsychology|September 17, 2004
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIVSteven Paul Woods, Julie D Rippeth, Alan B Frol, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2012
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohortBenjamin B Gelman, Joshua G Lisinicchia, Susan Morgello, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentrationDavid Croteau, Steven S Rossi, Brookie M Best, et al.
AIDS (London, England)|March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIVRowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Medical Virology|March 21, 2024
Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllersMattia Trunfio, Bin Tang, Oluwakemi Okwuegbuna, et al.
Journal of Neurovirology|June 13, 2015
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV diseaseAlbert M Anderson, Christine Fennema-Notestine, Anya Umlauf, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient CohortAlison C Kearns, Fengming Liu, Shen Dai, et al.
The Lancet. HIV|June 19, 2019
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort studyAlessandro Livelli, Florin Vaida, Ronald J Ellis, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluidDavid Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Clinical and Experimental Neuropsychology|September 17, 2004
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIVSteven Paul Woods, Julie D Rippeth, Alan B Frol, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2012
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohortBenjamin B Gelman, Joshua G Lisinicchia, Susan Morgello, et al.
Pageof 23